Literature DB >> 9649303

NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin.

A Gelasco1, S J Lippard.   

Abstract

The structure of the DNA duplex dodecamer, d(CCTCTGGTCTCC. GGAGACCAGAGG), containing the cisplatin d(GpG) 1,2-intrastrand cross-link at the position denoted by asterisks, was determined in solution by high-resolution 2D NMR spectroscopy and restrained molecular dynamics refinement. The cis-[Pt(NH3)2¿d(GpG-N7(1), N7(2))¿] lesion causes the adjacent guanine bases to roll toward one another by 49 degrees, leading to an overall helix bend angle of 78 degrees. These features are more exaggerated than those observed in the X-ray crystal structure determined for the same platinated duplex [Takahara et al. (1995) Nature 377, 649-652]. A common property of the solution and crystal structures is the widening and flattening of the minor groove opposite the platinum adduct, affording geometric parameters resembling those found in A-form DNA. This deformation is especially noteworthy for the solution structure because its sugar puckers are primarily those of B-form DNA. The unwinding of the helix at the site of platination is 25 degrees. The curvature and shape of the platinated duplex are remarkably similar to those observed in DNA duplexes complexed by the HMG-domain proteins SRY and LEF-1. The structure reveals how cisplatin binding alters DNA in such a manner as to facilitate HMG-domain protein recognition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649303     DOI: 10.1021/bi973176v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  Potent inhibition of werner and bloom helicases by DNA minor groove binding drugs.

Authors:  R M Brosh; J K Karow; E J White; N D Shaw; I D Hickson; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

2.  Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.

Authors:  C Hofr; N Farrell; V Brabec
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

3.  HMG-D complexed to a bulge DNA: an NMR model.

Authors:  R Cerdan; D Payet; J C Yang; A A Travers; D Neuhaus
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

4.  Local sequential minimization of double stranded B-DNA using Monte Carlo annealing.

Authors:  Konstantinos Sfyrakis; Astero Provata; David C Povey; Brendan J Howlin
Journal:  J Mol Model       Date:  2004-03-24       Impact factor: 1.810

5.  Molecular mechanisms and kinetics between DNA and DNA binding ligands.

Authors:  Andy Sischka; Katja Toensing; Rainer Eckel; Sven David Wilking; Norbert Sewald; Robert Ros; Dario Anselmetti
Journal:  Biophys J       Date:  2004-10-29       Impact factor: 4.033

6.  Pt-bridges in various single-strand and double-helix DNA sequences. DFT and MP2 study of the cisplatin coordination with guanine, adenine, and cytosine.

Authors:  Matej Pavelka; Jaroslav V Burda
Journal:  J Mol Model       Date:  2006-09-20       Impact factor: 1.810

Review 7.  Binding of kinetically inert metal ions to RNA: the case of platinum(II).

Authors:  Erich G Chapman; Alethia A Hostetter; Maire F Osborn; Amanda L Miller; Victoria J DeRose
Journal:  Met Ions Life Sci       Date:  2011

8.  Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.

Authors:  Jana Kasparkova; Miroslav Fojta; Nicholas Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

9.  Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.

Authors:  Bassant M Barakat; Qi-En Wang; Chunhua Han; Keisha Milum; De-Tao Yin; Qun Zhao; Gulzar Wani; El-Shaimaa A Arafa; Mohamed A El-Mahdy; Altaf A Wani
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

10.  Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.

Authors:  Hala Ouzon-Shubeita; Meghan Baker; Myong-Chul Koag; Seongmin Lee
Journal:  Biochem J       Date:  2019-02-28       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.